Menu

Consolidated Cash Flow Statement

37.5 KB EXCEL
€ million Note 2016 2015
Profit after tax 1,633 1,124
Depreciation / amortization / impairment losses / reversals of impairments 1,934 1,511
Changes in inventories 23 – 90
Changes in trade accounts receivable – 73 – 84
Changes in trade accounts payable 76 166
Changes in provisions – 51 215
Changes in other assets and liabilities – 587 – 636
Neutralization of gains / losses on disposal of assets – 451 – 42
Other non-cash income and expenses 14 32
Net cash flows from operating activities ➞ 33 2,518 2,195
thereof: from discontinued operations 6
 
Payments for investments in intangible assets – 132 – 179
Payments from the disposal of intangible assets 2 27
Payments for investments in property, plant and equipment – 716 – 514
Payments from the disposal of property, plant and equipment 21 9
Payments for investments in financial assets – 344 – 1,741
Payments for acquisitions less acquired cash and cash equivalents – 156 – 13,482
Payments from the disposal of other financial assets 457 3,858
Payments from divestments less transferred cash and cash equivalents 5
Payments from other divestments – 3
Payments from divestment of assets held for sale 364 86
Net cash flows from investing activities ➞ 34 – 503 – 11,936
thereof: from discontinued operations 24 84
 
Dividend payments to Merck KGaA shareholders – 136 – 129
Dividend payments to non-controlling interests – 3 – 4
Dividend payments to E. Merck KG – 461 – 435
Payments from new borrowings of financial liabilities from E. Merck KG 881 560
Repayments of financial liabilities to E. Merck KG – 729 – 484
Repayment of bonds – 272 – 1,738
Payments from issuance of bonds 5,756
Payments from new borrowings of other current and non-current financial liabilities 236 4,106
Repayments of other current and non-current financial liabilities – 1,424 – 470
Net cash flows from financing activities ➞ 34 – 1,908 7,164
thereof: from discontinued operations
 
Changes in cash and cash equivalents 107 – 2,577
Changes in cash and cash equivalents due to currency translation 8 531
Cash and cash equivalents as of January 1 832 2,879
Changes in cash and cash equivalents due to changes in scope of consolidation – 8
Cash and cash equivalents as of December 31 939 832
Plus cash and cash equivalents included in assets held for sale
Cash and cash equivalents as of December 31 (consolidated balance sheet) ➞ 23 939 832